COVID-19 Haemodialysis: Ensuring Patient Safety

Archived Content Notice

You are currently accessing the Think Kidneys website. Please be aware that this site is an archive and contains content from the Think Kidneys project, which concluded in 2019. As a result, the information presented here is no longer being updated or maintained.

For the most current and relevant information, we encourage medical professionals to visit the UK Kidney Association for comprehensive resources and updates in the field. Patients and their families can find valuable, patient-centric information and support at Kidney Care UK.

We would also like to inform you that the Kidney Quality Improvement Partnership (KQIP) is now part of the UK Kidney Association. For more information, please visit KQIP’s homepage under the UK Kidney Association.

We thank you for your understanding and invite you to explore these recommended resources for up-to-date insights and guidance in kidney care and health.

Subgroup of the national Renal COVID Haemodialysis Special Interest Group

Aims and objectives

This group aims to ensure the safety of in-centre haemodialysis outpatients during the COVID-19 pandemic and as normal services are restored by doing the following:

  • Respond to concerns from patients and staff on issues relevant to the safety and patient experience of outpatient haemodialysis care
  • Work with stakeholders to identify knowledge gaps in the prevention of transmission of COVID-19 to patients and staff in a haemodialysis unit
  • Work with stakeholders to develop evidence based practice by utilising research and quality improvement methods
  • Provide an online hub of learning and evidence on haemodialysis patient safety during the COVID-19 pandemic to facilitate the spread of best practice across UK renal units.

Latest outputs

Driver diagram

Partner organisations

For further information, please get in touch with the KQuIP team at KQUIP@RenalRegistry.nhs.uk